Intrathecal drug delivery involves administering analgesic medications directly into the cerebrospinal fluid, thereby achieving targeted pain relief while minimising systemic side effects. This method ...

Panelists discuss how emerging intrathecal gene therapy for older patients with spinal muscular atrophy (SMA) shows modest efficacy with fewer systemic adverse effects than intravenous administration, ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. Food and Drug Administration has approved its iohexol injection (300 mg Iodine/mL), the first generic version of GE Healthcare's ...

The author(s) indicated no potential conflicts of interest. Corresponding author: Peter J. Gilbar, BPham, MPallC, Cancer and Palliative Care Services, Toowoomba Hospital, Toowoomba QLD 4350, Australia ...

As we began entered the holiday season last year, we had just learned that a 69-year-old woman had died due to a medication error that was caused in large part by an ...

Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...